olympia grand • london • united kingdom€¦ · and vascular surgeon at the university heart...
Post on 12-Aug-2020
4 Views
Preview:
TRANSCRIPT
EDUCATION INNOVATION EVIDENCE
YEARS
OF LOOKING
FORWARD
First Announcement
AorticControversies
AcuteStroke
Controversies
VenousControversies
10 Years ofCX VenousWorkshop
PeripheralArterial
Controversies
Interdisciplinary Leg Initiative
10 Years of
Controversies UpdateVascular & Endovascular
24–27 APRIL 2018OLYMPIA GRAND • LONDON • UNITED KINGDOM
Years of Looking Forward
2 Vascular & Endovascular Controversies Update
Chairman
Roger Greenhalgh Emeritus Professor of Surgery and Head of Vascular
Surgery Research Group at Imperial College London, London, UK
Co-chairmen
Frans Moll Emeritus Professor of Vascular Surgery at University
Medical Center Utrecht, Utrecht, Netherlands
Stéphan Haulon Professor of Vascular Surgery, Université Paris Sud,
Hôpital Marie Lannelongue, Le Plessis Robinson, France
Andrew Holden Associate Professor of Radiology at Auckland University
School of Medicine and Director of Interventional Services at Auckland City Hospital, Auckland, New Zealand
Aortic
Dittmar Böckler Professor of Vascular Surgery at University of
Heidelberg and Head of Department of Vascular Surgery and Endovascular Surgery at University Hospital Heidelberg, Heidelberg, Germany
Giovanni Torsello Emeritus Professor, Department of Vascular Surgery
at Franziskus Hospital and Director of the Clinic for Vascular and Endovascular Surgery at the University of Münster, Münster, Germany
Tilo Kölbel Professor of Vascular Surgery, University of Hamburg,
and Vascular Surgeon at the University Heart Center Hamburg, Hamburg, Germany
Frank Vermassen Professor in Vascular and Thoracic Surgery Department
of Vascular Surgery at Ghent University Hospital, Ghent, Belgium
Late-Breaking Aortic Trials
Janet Powell Professor of Vascular Biology and Medicine, Imperial
College London, London, UK
We are pleased to invite you to join us once again in London, UK, for the Charing Cross International Symposium 2018, the vascular and endovascular annual meeting where education, innovation and evidence merge in one place.
For 40 years, CX has continually looked forward, raising vascular and endovascular controversies so that a world-class faculty challenges the available evidence in order to reach a consensus after discussion with an expert audience. This forms a three-year cycle.
In 2018, the programme will focus on controversies in all aspects of vascular disease management and we will be introducing new and exciting activities, with an increase in hands-on workshops and live and edited cases. Also in 2018, the CX Venous Workshop and ilegx will be celebrating their 10th anniversaries.
At CX 2018, the programmes for the Aortic, Peripheral Arterial, Venous, Acute Stroke and Vascular Access tracks have been designed in sequence rather than in parallel so that CX attendees can maximise their participation.
We look forward to welcoming you to CX 2018!
CX Programme Organising Board
NEW for CX 2018• Peripheral Arterial live case transmissions and from
multiple centres
• CX Aortic, CX Peripheral Arterial and CX Vascular Access Villages for dedicated hands-on workshops in addition to the CX Venous Workshop (10th anniversary)
• ilegx (10th anniversary)
• High profile Late-Breaking Aortic, Peripheral Arterial and Venous Clinical Trial Sessions
• Techniques & Technologies Sessions for Aortic, Peripheral Arterial, Venous and Vascular Access
• Far more opportunities for interaction with CX Faculty and exhibitors
• CX "40 Years of Looking Forward" Thursday Party
24–27 April 2018
3
Peripheral Arterial
Cliff Shearman Professor of Vascular Surgery at University of
Southampton and Vascular Surgeon in the Department of Vascular Surgery, University Hospital Southampton Foundation Trust, Southampton, UK
Michael Edmonds Professor of Diabetic Foot Medicine and Consultant
Diabetologist at King’s College Hospital, London, UK
Thomas Zeller Professor of Angiology at Albert-Ludwigs University
of Freiburg and Head of Department of Angiology at Universitäts – Herzzentrum Freiburg, Bad Krozingen,
Germany
Giovanni Torsello Emeritus Professor, Department of Vascular Surgery
at Franziskus Hospital and Director of the Clinic for Vascular and Endovascular Surgery at the University of Münster, Münster, Germany
Iris Baumgartner Professor and Head of Clinical and Interventional
Angiology and Director of Vascular Research at University Hospital Bern, Bern, Switzerland
Trevor Cleveland Consultant Vascular Radiologist and Honorary Senior
Lecturer at Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
Frank Vermassen Professor in Vascular and Thoracic Surgery Department
of Vascular Surgery at Ghent University Hospital, Ghent, Belgium
Late-Breaking Peripheral Arterial Trials
Venous
Ian Franklin Consultant Vascular Surgeon at London Vascular Clinic,
London, UK
Stephen Black Consultant Vascular Surgeon at Guy’s and St Thomas’
Hospital, London, UK
Alun Davies Professor of Vascular Surgery at Imperial College
London and Consultant General Surgeon at Charing Cross Hospital, London, UK
Late-Breaking Venous Trials
Alun Davies Professor of Vascular Surgery at Imperial College
London and Consultant General Surgeon at Charing Cross Hospital, London, UK
Congenital Vascular Malformations
Krassi Ivancev (Chairman) Consultant Interventional Radiologist, Royal Free
London, Honorary Professor, Division of Surgery & Interventional Sciences, Faculty of Medical Sciences, University College London
Iris Baumgartner Professor and Head of Clinical and Interventional
Angiology and Director of Vascular Research at University Hospital Bern, Bern, Switzerland
George Hamilton Consultant Vascular Surgeon, Royal Free NHS Hospital
and Great Ormond Street Hospital for Children, Professor, University College London, London, UK
Malcolm Simms Consultant Vascular Surgeon, Birmingham, UK
Acute Stroke
Ross Naylor Honorary Professor of Vascular Surgery at University of
Leicester and Consultant Vascular Surgeon at Leicester Royal Infirmary, Leicester, UK
Hugh Markus Professor of Stroke Medicine, Honorary Consultant
Neurologist, University of Cambridge, Cambridge, UK
Next-Generation Vascular Specialists
Rob Hinchliffe Clinical Professor of Vascular Surgery at University of
Bristol and Vascular Surgeon at North Bristol NHS Trust, Bristol, UK
Vascular Access
Nicholas Inston Consultant Surgeon and Clinical Lead for Renal Surgery
and Transplantation at Queen Elizabeth Hospital Birmingham, Birmingham, UK
Domenico Valenti Consultant Vascular Surgeon and Honorary Senior
Lecturer at King’s College London, London, UK
CX Abstract BoardIan LoftusMeryl Davis Richard Gibbs
Robert HinchliffeColin BicknellDaryll Baker
Rachel BellMarcus BrooksSimon Ashley
International AdvisorsPatrick PeetersEric Verhoeven
Gunnar TepeJan Brunkwall
Eric ChemlaMatt Thompson
Years of Looking Forward
4 Vascular & Endovascular Controversies Update
CX 2018 Preliminary Programme Highlights
• What counts in deciding to intervene in claudicants
• When to intervene for the SFA + treatment algorithm by lesion type (DCBs vs DES + stents vs PTA)
• Endovascular first vs bypass first for critical limb ischaemia
• Tibial angioplasty vs infrapopliteal bypass + plantar loop angioplasty vs plantar bypass
• Role of gene therapy and deep venous arterialisation for “no option” CLI
Late-breaking peripheral arterial and wound healing trials
Day 2: NEW Peripheral Techniques & Technologies (Live Cases)Wednesday, 25 April 2018
Day 3: ilegx – focused on saving legsThursday, 26 April 2018
NEW CX Peripheral Arterial Workshop – Peripheral Village
CX Abstracts and E-posters
3 Days of Peripheral Arterial ControversiesDay 1: Plenary Programme – Tuesday, 24 April 2018 Additional Peripheral Sessions
Abdominal Aortic Controversies
• Value of screening programmes in men with AAA
• Role of sac sealing technologies
• Conversion after EVAR / EVAS
• Impact of centralisation + EVAR on the treatment of ruptured aneurysms
• ChEVAR vs FEVAR vs CHEVAS vs ChFEVAR vs open repair in aneurysms with short necks
• Treatment of mycotic aneurysm: EVAR vs open surgery
Thoracic Aortic Controversies
• Correlation of volume and outcome for TEVAR + open surgery
• Outcomes of TEVAR for chronic type B dissection
• TEVAR treatment of ruptured descending thoracic aortic aneurysms
• Open thoracoabdominal aortic aneurysm repair after failed TEVAR
• Endovascular techniques in trauma (REBOA) and pelvic embolization
• Treatment of mycotic thoracic aortic aneurysms
Late-breaking aortic trials
3 Days of Aortic ControversiesDay 2: Plenary Programme – Wednesday, 25 April 2018 Additional Aortic Sessions
Day 1: NEW Aortic Techniques & Technologies (Edited Cases)Tuesday, 24 April 2018
NEW CX Aortic Workshop – Aortic Village
CX Abstracts and E-posters
Day 3: Plenary Programme – Thursday, 26 April 2018
24–27 April 2018
5
Carotid and Vertebral Controversies
• Debates based on the ESVS carotid/vertebral guidelines 2017/2018
Acute Stroke Controversies
• Stroke from Thoracic Endovascular Procedures (STEP) – Incidence and global collaboration for optimal results
CX Abstracts and E-posters
Acute Stroke ControversiesDay 1: Plenary Programme – Friday 27, April 2018 Additional Acute Stroke Sessions
Complex and end stage vascular access
• Upper limb complex access (basilic veins vs arteriovenous grafts)
• Lower limb access (autologous vs arteriovenous grafts vs HeRO)
• Maintaining access in central venous catheter occlusion – role of central stents
• Best treatment for total venous occlusion
Late-breaking trials in vascular access
Day 2: CX Vascular Access Workshop – Techniques & TechnologiesThursday, 26 April 2018
CX Abstracts and E-posters
2 Days of Vascular Access CourseDay 1: Plenary Programme – Wednesday, 25 April 2018 Additional Vascular Access Sessions
• Pharmacomechanical thrombolysis vs medical treatment for acute DVT
• Deep venous stenting for chronic venous diseases
• Mechanochemical ablation (MOCA) and adhesive closure
• Downsides of adhesive closure and thermal ablation
• Early vs delayed endovenous treatment of superficial venous reflux
Late-breaking trials for venous disease and CCSVI
Day 2: NEW Venous Techniques & Technologies (Edited Cases)Wednesday, 25 April 2018
Days 2 and 3: CX Venous Workshop – Venous CityWednesday, 25 April and Thursday, 26 April 2018
CX Abstracts and E-posters
3 Days of Venous ControversiesDay 1: Plenary Programme – Tuesday, 24 April 2018 Additional Venous Sessions
Years of Looking Forward
6 Vascular & Endovascular Controversies Update
Abstract submission deadline: Sunday, 22 October 2017The Charing Cross Symposium invites senior and trainee clinicians working in the vascular and endovascular field to submit an abstract to be considered for presentation at the CX Open Abstract Session or as an Electronic Poster
Best Abstract awards:The best abstract presentation in each category (senior and trainee) will be awarded £1,000 and a diploma for best presentation. The best Electronic Poster presentation will receive complimentary registration for CX 2019.
Abstracts to be presented in the CX Vascular Access Programme will be judged separately and the best presentation will be awarded £500.
Prize and Certificate of Merit winners will be invited to submit topics for the CX Plenary Programme for 2019.
Visit www.cxsymposium.com/abstracts to submit your abstract.
Call for Abstracts for CX 2018
Areas for submission include: • Peripheral Arterial
• Abdominal Aortic
• Thoracic Aortic
• Acute Stroke
• Venous
• Vascular Access
Abstract acceptance leads to: • Inclusion of abstracts in the CX Abstract Book
• Inclusion of name and title in the CX Final Programme
• Complimentary registration for CX 2018 (trainee clinicians only)
• A chance to receive a Certificate of Merit for outstanding presentation
Additional CX Course Additional CX Sessions
Additional CX Courses and Sessions
CX Congenital Vascular Malformations
CX Innovation Showcase
CX Meets Latin America
CX Meets China
24–27 April 2018
7
What has made CX so special over 40 years of looking forward?
CX 4-DAY RATE (Access all areas, including Vascular Access)
CX 1-DAY RATE(Access all areas for Tuesday, Wednesday or Thursday)
Early bird* Standard rate Late / onsite registration** Early bird* Standard rate Late / onsite
registration**
Physician (Excluding juniors, trainees, fellows, interns)
£695 £795 £895 £295 £345 £385
Junior 1
(Includes Trainees, Fellows, Interns)
£345 £395 £445 £150 £180 £195
Vascular technologist 1 / Nurse 1 £145 £175 £195 £75 £95 £105
The 4-day rate includes the symposium book The 1-day rate(s) excludes the symposium book
CX ACUTE STROKE – FRIDAY
Early bird* Standard rate Late/onsite registration**
£95 £115 £125Note: Friday only. Excludes symposium book. Bag
will be subject to availability.
Registration & AccommodationEarly Bird Registration Deadline: Sunday, 25 February 2018
* Early bird rates are valid on applications received before midnight on 25th February 2018.** Late/onsite registration applies after Friday 20th April 2018.1 This fee is subject to verification of status in the form of a letter from your head of department.
Book your accommodation close to the venue at special rates.For CX we partner with various nearby hotels to give you a selection of options at preferential rates. Please visit www.cxsymposium.com/hotels for more information.
Register at www.cxsymposium.com/registration
“CX has always been a good meeting to challenge my thinking. It has allowed me to participate in interesting
conversations and to gain—particularly with the workshops—tips and tricks for my own practice.” Stephen Black, London, UK
“ Each year I attend CX I come away with consensus messages that change or improve my practice and
that I can share with my colleagues. I look forward to next year being the same.” Andrew Holden, Auckland, New Zealand
“ At CX we discuss clinical science getting information about what is up to date with regards to new
developments and technologies in the light of what is considered as being the benchmark.” Thomas Zeller, Bad Krozingen, Germany
“ CX is optimal education! The symposium provides us with really strong evidence for what we are doing
every day, leading to appropriate decision-making for patients.” Dittmar Böckler, Heidelberg, Germany
CX SYMPOSIUM @CXSYMPOSIUM
www.cxsymposium.com
YEARS
OF LOOKING
FORWARD
KEY MILESTONES
Controversies UpdateVascular & Endovascular
24–27 APRIL 2018OLYMPIA GRAND • LONDON • UNITED KINGDOM
2011 Andres Schanzer
and Roy Green-
berg’s study on
the importance
of adhering to IFU’s for EVAR
is presented at CX as well as
published in Circulation
General enquiries Charing Cross Symposium, 526 Fulham Road, London SW6 5NR, United Kingdom
Tel: +44 (0) 20 7736 8788, Fax: +44 (0) 20 7736 8283, Email: info@cxsymposium.com
1986Andreas Grüntzig, the father
of percutaneous transluminal
angioplasty, presents at CX
1987Michael DeBakey,
inventor of the
heart pump,
takes part in CX,
leading to the
creation of ESVS
1990Julio Palmaz
presents
‘stent graft
concept’ at
CX
2010The EVAR Trials 10-Year
Results are presented at CX
and simultaneously published
in the NEJM
2015Gunnar Tepe
presents the
one-year
results from the
IN.PACT SFA
Randomised Trial
top related